Ching W. Chong,Robert Kuehl,Heow Tan,Harisha Atluri
申请号：
US15909779
公开号：
US10010507B1
申请日:
2018.03.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Described herein are pharmaceutical formulations of Brutons tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
